The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma
This paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody. This case suggests a novel and unintentional effect of this therapy. Currently omalizumab is only FDA approved for the treatment of moderate-persistent allergic asthma. Howeve...
Saved in:
Main Authors: | Evelyn M. Slaughter, Nathan Boyer, Steven Bennett |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/138963 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Unusual Case of Bilateral Empyema Associated with Bee Sting
by: Srinivasa Kaligonahalli Venkataramanappa, et al.
Published: (2014-01-01) -
Two episodes of biphasic anaphylaxis in a boy allergic to wasp sting. Case report
by: Izabela Pędzik-Nowak, et al.
Published: (2024-09-01) -
Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients
by: Ruiqi Qian, et al.
Published: (2024-01-01) -
A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
by: Azusa Okude, et al.
Published: (2012-01-01) -
Stings of Ants of the Leptanillinae (Hymenoptera: Formicidae)
by: Charles Kugler
Published: (1992-01-01)